Ocular Therapeutix (OCUL) Debt Ratio (2013 - 2026)

Ocular Therapeutix (OCUL) recorded quarterly Debt Ratio of 0.1 in Q1 2026, up 11.43% quarter-over-quarter from 0.09 in Q4 2025, and down 42.3% on a YoY basis from 0.17 in Q1 2025.

Ocular Therapeutix (OCUL) Debt Ratio (2013 - 2026) Analysis & Trends

Ocular Therapeutix's Debt Ratio history runs 14 years deep, the most recent figure standing at 0.1 for Q1 2026.

  • In Q1 2026, Debt Ratio fell 42.3% year-over-year to 0.1; the TTM figure through Mar 2026 stood at 0.1 (down 42.3% YoY), while the FY2025 annual figure was 0.09, down 40.99% from the prior year.
  • Debt Ratio was 0.1 for Q1 2026 at Ocular Therapeutix, up from 0.09 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.4 in Q3 2023 to a low of 0.09 in Q4 2025.
  • Historically, Debt Ratio has averaged 0.17 across 5 years, with a median of 0.15 in 2025.
  • The sharpest annual moves came in 2023 and 2024: Debt Ratio jumped 152.45% in 2023, then plunged 65.52% in 2024.
  • A 5-year view of Debt Ratio shows it stood at 0.17 in 2022, then jumped by 54.27% to 0.26 in 2023, then tumbled by 42.68% to 0.15 in 2024, then slumped by 40.99% to 0.09 in 2025, then rose by 11.43% to 0.1 in 2026.
  • The last three Debt Ratio figures came in at 0.1 (Q1 2026), 0.09 (Q4 2025), and 0.17 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.18
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Ocular Therapeutix 2.12 Bn 2.12 Bn 9.46 Mn 0.10

Historic Data

Download Data
DateValue
Mar 31, 2026 0.10
Dec 31, 2025 0.09
Sep 30, 2025 0.17
Jun 30, 2025 0.15
Mar 31, 2025 0.17
Dec 31, 2024 0.15
Sep 30, 2024 0.14
Jun 30, 2024 0.13
Mar 31, 2024 0.12
Dec 31, 2023 0.26
Sep 30, 2023 0.40
Jun 30, 2023 0.19
Mar 31, 2023 0.20
Dec 31, 2022 0.17
Sep 30, 2022 0.16
Jun 30, 2022 0.15
Mar 31, 2022 0.13
Dec 31, 2021 0.12
Sep 30, 2021 0.11
Jun 30, 2021 0.11